Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Investment Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

BB Biotech AG

+ Add to Watchlist

BIO:EB

268.2000 EUR 5.0000 1.90%

As of 11:30:00 ET on 02/27/2015.

Snapshot for BB Biotech AG (BIO)

Open: 268.2000 High - Low: 268.2000 - 268.2000 Primary Exchange: BATS Europe
Volume: 8 52-Week Range: 113.8000 - 268.2000 Beta vs NBI: 0.8417

ETF Chart for BIO

No chart data available.
  • BIO:EB 268.2000
  • 1D
  • 1M
  • 1Y
263.2000
Interactive BIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BIO

BB Biotech AG is an investment company. The Company invests in biotech companies that operate in areas that include oncology, cardiovascular diseases, infectious diseases and autoimmune diseases.

Inception Date: Telephone: Tel: +41 44 267 67 00
Managers: DANIEL KOLLER
Web Site: www.bellevue.ch/cms/home/bellevue_asset_management

Fundamentals for BIO

NAV -
Assets (M) -
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for BIO

Dividend Type Return of Capital
Dividend Frequency Annual
Last Dividend Net (on 2015-03-20) 11.6000
Dividend Yield (ttm) 2.14%

Performance for BIO

1-Month +5.61% 1-Year +91.14%
3-Month +44.54% 3-Year -
Year To Date +35.73% 5-Year -
Expense Ratio 1.02

Top Fund Holdings for BIO

Filing Date: 12/31/2014
Name Position Value % of Total
Celgene Corp 3,714,298 412,900,000 11.385%
Isis Pharmaceuticals Inc 5,976,526 366,700,000 10.111%
Incyte Corp 4,051,867 294,400,000 8.118%
Gilead Sciences Inc 2,945,596 276,000,000 7.610%
Actelion Ltd 2,289,385 264,000,000 7.279%
Agios Pharmaceuticals Inc 1,864,921 207,700,000 5.727%
Vertex Pharmaceuticals Inc 1,354,445 159,900,000 4.409%
Medivation Inc 1,384,706 137,100,000 3.780%
Alexion Pharmaceuticals Inc 672,428 123,700,000 3.411%
Radius Health Inc 2,752,140 106,400,000 2.934%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil